5 Medical Device Stocks for 2021
In this article we discuss the 5 medical device stocks for 2021.
Posts Tagged ‘NYSE:ABT’
10 Best Healthcare Stocks to Buy According to Hedge Funds
In this article, we will take a look at some of the best healthcare stocks to buy based on the data of over 860 hedge funds tracked by Insider Monkey.
Is Abbott Laboratories (ABT) Going to Burn These Hedge Funds?
The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive...
Polen Global Growth: “Abbott Laboratories (ABT) Continues to be Fairly Valued”
Polen Capital, an investment management firm, published its “Polen Global Growth” first quarter 2021 investor letter – a copy of which can be downloaded here.
10 Best Pharma Stocks to Buy Now
In this article we will take a look at the 10 best pharma stocks to buy now.
5 Best Pharma Stocks to Buy Now
In this article we discuss the 5 best pharma stocks to buy now.
Is Abbott Laboratories (ABT) Stock A Buy or Sell?
A whopping number of 13F filings filed with U.S.
Here’s Why Polen Capital Likes Abbott Laboratories (ABT) Stock
Polen Capital Management, a value-driven, concentrated, long-term investment management firm, published its ‘Polen Global Growth’ fourth-quarter 2020 Investor Letter – a...
Is Abbott Laboratories (ABT) a Smart Long-term Buy?
Baron Health Care Fund recently published its third-quarter commentary – a copy of which can be downloaded here.
Is ABT A Good Stock To Buy Now?
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Top 5 Earnings Growth Stocks with Dividends for 2021
Below we present the list of Top 5 Earnings Growth Stocks with Dividends for 2021.
10 Best Growth Stocks To Buy Now According To Ray Dalio
In this article, we present the list of 10 best growth stocks to buy now according to billionaire Ray Dalio.
Top 10 Stocks Billionaire Ray Dalio Just Bought
Ray Dalio is the billionaire Founder, Co-Chairman and Co-Chief Investment Officer of Bridgewater Associates, the largest hedge fund in the world with over $140 billion in assets...
Polen Capital is Betting on Abbott Laboratories (ABT) Stock
Polen Capital Management recently released its Q3 2020 Investor Letter, a copy of which you can download here.
Were Hedge Funds Right About Crowding Into Abbott Laboratories (ABT)?
In this article we will take a look at whether hedge funds think Abbott Laboratories (NYSE:ABT) is a good investment right now.
Hedge Funds Never Been This Bullish On Abbott Laboratories (ABT)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file ...
Abbott Laboratories (ABT): Were Hedge Funds Right About This Stock?
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
Abbott Laboratories (ABT): Hedge Funds Are In Wait-and-See Mode
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Why Polen Capital is Bullish on Abbott Laboratories (ABT)
Polen Capital Management, LLC, an independently-owned global investment manager, recently published its first-quarter focus growth commentary – a copy of which can be downloaded...
Were Hedge Funds Right About Abbott Laboratories (ABT)?
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Hedge Funds Have Never Been This Bullish On Abbott Laboratories (ABT)
Is Abbott Laboratories (NYSE:ABT) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock.
Abbott Laboratories (ABT) vs. Hedge Fund Favorites in 2019
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Hedge Funds Have Never Been This Bullish On Abbott Laboratories (ABT)
A whopping number of 13F filings filed with U.S.
Were Hedge Funds Right About Abandoning Abbott Laboratories (ABT)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Here’s What Hedge Funds Think About Abbott Laboratories (ABT)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Hedge Fund and Insider Trading News: Kyle Bass, Davidson Kempner, AQR Capital Management, Platinum Partners, Turning Point Therapeutics, Inc. (TPTX), Hooker Furniture Corporation (HOFT), and More
Kyle Bass, the often-bearish hedge-fund manager who won big during the global financial crisis, has trained his sights anew on the Hong Kong dollar. Mr.
Hedge Fund and Insider Trading News: Daniel Loeb, Ray Dalio, Edward Lampert, Linde PLC (LIN), Gaia Inc (GAIA), and More
Financier Ray Dalio is on a mission to let everyone know that wealth inequality has become so extreme it is driving a dangerous wedge in society.
Were Hedge Funds Right About Selling Abbott Laboratories (ABT)?
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics ...
Is Abbott Laboratories (ABT) A Good Stock To Buy?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Market Movers Today: W W Grainger Inc (GWW), Cerus Corporation (CERS), Texas Instruments Incorporated (TXN), and More
What happened: Shares of industrial supplier WW Grainger Inc (NYSE:GWW) jumped as much as 17.4% in trading Wednesday after the company reported fourth-quarter results that topped...
Top 75 Healthcare Dividend Stocks To Invest In
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.
Alere Inc (ALR) Surges on Amended Buyout News
Alere Inc (NYSE:ALR) has surged 16% in the pre-market after the Abbott Laboratories (NYSE:ABT) finally bit the bullet and agreed to an amended merger to buy Alere for $51 per...
GDS Investments Shares Bullish Theses on FMC, GM, Mosaic, More
GDS Investments, a premier investment management firm headed by Glenn D.
Locust Wood Boosts Exposure to These Companies
Locust Wood Capital Advisers is a New York-based hedge fund that was founded in 2002 by Stephen J. Errico with a capital of $29 million.
Abbott Laboratories (ABT)’s Molecular Test For Detecting Zika Virus Approved By The FDA
The Abbott RealTime ZIKA molecular test from Abbott Laboratories (NYSE:ABT) has gained the approval of the U.S. Food and Drug Administration (FDA).
Abbott Laboratories (ABT) Pacemakers Get FDA Approval
The Tendril MRI pacing lead and the Assurity MRI pacemaker have been approved by the U.S. Food and Drug Administration.
ACCURATE Study Confirms Superiority Of Abbott Laboratories (ABT) Dorsal Root Ganglion (DRG) Stimulation
Abbott Laboratories (NYSE:ABT)'s dorsal root ganglion (DRG) stimulation therapy has advantages over traditional spinal cord stimulation (SCS) in the treatment of patients suffering...
Alinity ci-series Of Diagnostic Systems From Abbott Laboratories (ABT) Obtains CE Mark
Alinity, a family of next-generation clinical chemistry and immunoassay diagnostics from Abbott Laboratories (NYSE:ABT) is now being offered in Europe and other countries that...
Cluster of Insider Buying at Inovalon Holdings Inc. (INOV) after Slashing Guidance, Plus Other Noteworthy Pre-Holiday Insider Transactions
Corporate insiders such as Board members and executives usually buy shares on the open market for one simple reason – they believe Mr.
Billionaire Druckenmiller’s Top Dividend Stock Picks
Stanley Druckenmiller was one of the fund managers for the Quantum Fund founded by George Soros.
Dividend Growth Stocks For Further Research
Each week I review the list of dividend increases as part of my monitoring process.
The Smart Money’s Confidence in Abbott Laboratories (ABT) Continues to Rise
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers...
Abbott Laboratories (ABT) Dragging Alere Inc (ALR) To Court
Abbott Laboratories (NYSE:ABT) has sued Alere Inc (NYSE:ALR), a diagnostics company it agreed to acquire earlier this year, for breach of contract.
Mairs & Power Adds Alphabet (GOOGL), Thinks Wells Fargo (WFC) Has Been Overly Punished
Mairs & Power is a Minnesota-based hedge fund with $4.32 billion worth of assets invested in 52 holdings in its U.S. public equity portfolio.
George Soros Isn’t Just A Controversial Political Figure; He Also Owns A Lot of Stocks, And These Are His Long-Term Favorites
Billionaire George Soros has been in the news a lot during the current Presidential elections, most recently being at the center of controversy over his ties to a company that...
Here’s Why Investors Are Watching Sangamo Biosciences, GNC Holdings, and Three Other Stocks Today
Markets are mixed on Wednesday as investors get ready to digest a flurry of earnings, and await Federal Reserve’s summary of commentary of the current economic condition, also...
The Smart Money Loves These Dividend Aristocrats: Wal-Mart, Chevron, More
Dividend Aristocrats have passed the test of time.
Tesla, TerraForm, and Johnson & Johnson Among the Biggest Weekend Newsmakers
With another quarter almost in the rear-view mirror, many investors are adjusting their portfolios in reaction to the latest news.
5 Healthcare Stocks Near the Top of Cheyne Capital’s Portfolio
London-based Cheyne Capital recently disclosed its U.S. equity portfolio via a 13F filing submitted with the SEC.
Did Hedge Funds Anticipate These M&A Deals?
Antitrust regulations, tax rules and political uncertainty marred the Merger & Acquisitions (M&A) activity in the second quarter of 2016.
